Mersana Therapeutics buy Guggenheim
Start price
14.06.23
/
50%
€5.54
Target price
14.06.24
-
Performance (%)
-66.10%
End price
15.06.24
€1.88
Summary
This prediction ended on 15.06.24 with a price of €1.88. The BUY prediction by Guggenheim for Mersana Therapeutics performed very badly with a performance of -66.10%. Guggenheim has a follow-up prediction for Mersana Therapeutics where he still thinks Mersana Therapeutics is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mersana Therapeutics | - | - | - |
| iShares Core DAX® | 0.648% | 1.259% | 33.177% |
| iShares Nasdaq 100 | -0.034% | 2.797% | 14.536% |
| iShares Nikkei 225® | 2.445% | 9.854% | 9.686% |
| iShares S&P 500 | 0.492% | 2.570% | 10.401% |
Comments by Guggenheim for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.31
16.05.25
16.05.25
€4.46
16.05.26
16.05.26
-14.13%
25.07.25
25.07.25
